Browse: Companies | People | Financial Organizations
Home > Companies > GlaxoSmithKline

Exit

PublicGSK

General Information

Websitegsk.com
CategoryBioTech
Phone+44 (0)20 8047 5000
Employees
DescriptionHIV, TB pharmaceuticals

Offices

Former People

Statistician

Acquisitions

Total$4.38B
Stiefel, 4/09 $3.6B
Genelabs Technologies, 11/08 $57M
Sirtris Pharmaceuticals, 4/08 $720M

Investments

Tags

GlaxoSmithKline

GSK is a UK-based pharmaceutical and healthcare company focusing on research to develop and distribute treatments for HIV/AIDS, TB, and malaria. They also distribute some OTC products.

Milestones

  • Invested in Genmab. (10/09)
    Posted 10/27/09 at 11:29pm
  • Invested in Chroma Therapeutics. (6/23/09)
    Posted 7/7/09 at 12:28pm
  • Acquired Stiefel for $3.6B. (4/20/09)
    Posted 6/26/09 at 1:14pm
  • Acquired Genelabs Technologies for $57M. (11/08)
    Posted 9/10/09 at 3:01pm
  • Acquired Sirtris Pharmaceuticals for $720M. (4/22/08)
    Posted 5/21/08 at 2:03pm
  • Went public with stock symbol GSK.
    Posted 6/26/09 at 2:07pm
  • Sweta Sharma, Statistician added.
    Posted 6/5/09 at 12:46am

Videos

Screenshots

Stock Price

Sources

  1. Glaxo Bags Stiefel (forbes.com) [edit]
  2. More Layoffs: GSK Completes Purchase of Genelabs Technologies, Inc. (biojobblog.com) [edit]
  3. GlaxoSmithKline to acquire Sirtris Pharmaceuticals, a world leader in 'Sirtuin' research and development (phx.corporate-ir.net) [edit]
  4. Genmab wins $23M on blockbuster cancer approval (fiercebiotech.com) [edit]
  5. Capital Report Index [edit]

TechCrunch Posts TechCrunch Logo Small Picture

Techmeme Posts Techmeme Logo Small Picture

External Links

Embed Widget

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy